The National Workers’ Compensation and Disability Conference & Expo (NWCDC) is the only national conference devoted to workers’ compensation and disability management professionals. This conference also features the largest expo in the workers’ compensation industry. Mitchell | Genex | Coventry will have a dynamic exhibit display on the show floor at booth #527 and is happy to be a returning sponsor for this years’ conference. Please contact your Mitchell | Genex | Coventry representative for more information on this private event.
More stories
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Specialty Services Are a Big Deal
When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.
Enlyte Family of Companies Publish Inaugural Report Offering Trends and Predictions for Property & Casualty (P&C) and Collision Repair Industries
Under its new parent brand, Mitchell, Genex and Coventry launch first edition of Enlytened, examining continuing impact of COVID-19 on innovation and technology
Mitchell, Genex and Coventry Unite Under a Single, New Brand: Meet Enlyte
SAN DIEGO, CA—October 13, 2021—Mitchell, Genex and Coventry formally announced today the creation of their new parent brand, Enlyt